Case Report: Angioimmunoblastic T-cell lymphoma initially diagnosed as eosinophilic granulomatosis with polyangiitis.
증례보고
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: suspected EGPA who show an atypical or refractory course to conventional therapy
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
A definitive diagnosis often requires an adequate tissue sample, preferably from a surgical lymph node biopsy, to avoid misdiagnosis and ensure appropriate management. Respiratory physicians should maintain a high index of suspicion for lymphoid malignancies in such complex presentations.
[BACKGROUND] Eosinophilic granulomatosis with polyangiitis (EGPA) and angioimmunoblastic T-cell lymphoma (AITL) are distinct entities that can present with overlapping clinical features, posing a sign
APA
Ni Y, Sun Y, et al. (2025). Case Report: Angioimmunoblastic T-cell lymphoma initially diagnosed as eosinophilic granulomatosis with polyangiitis.. Frontiers in medicine, 12, 1716129. https://doi.org/10.3389/fmed.2025.1716129
MLA
Ni Y, et al.. "Case Report: Angioimmunoblastic T-cell lymphoma initially diagnosed as eosinophilic granulomatosis with polyangiitis.." Frontiers in medicine, vol. 12, 2025, pp. 1716129.
PMID
41657576 ↗
Abstract 한글 요약
[BACKGROUND] Eosinophilic granulomatosis with polyangiitis (EGPA) and angioimmunoblastic T-cell lymphoma (AITL) are distinct entities that can present with overlapping clinical features, posing a significant diagnostic challenge. This case highlights a critical diagnostic pitfall where AITL was initially misdiagnosed as EGPA.
[CASE PRESENTATION] A 55-year-old man presented in 2021 with recurrent wheezing, dyspnea, chronic sinusitis, peripheral eosinophilia (7.35 × 10⁹/L), and skin rash, leading to an initial diagnosis of asthma and later EGPA. Despite treatment with systemic corticosteroids, omalizumab, and mepolizumab, his respiratory symptoms persisted, and lymphadenopathy progressed. A fine-needle lymph node biopsy initially suggested Kimura disease. In 2024, the appearance of a parotid mass prompted further investigation. A subsequent surgical lymph node biopsy in 2025 revealed an effaced nodal architecture with a proliferation of atypical T-cell positive for CD3, CD5, ICOS, and PD-1. T-cell receptor gene rearrangement demonstrated clonality, and Epstein-Barr virus-encoded RNA was detected in situ. These findings confirmed the diagnosis of AITL. Treatment was switched to the CHOP chemotherapy regimen, leading to symptomatic improvement and normalization of eosinophil counts.
[CONCLUSION] This case underscores that AITL can closely mimic EGPA, presenting with severe asthma, hypereosinophilia, sinusitis, and systemic symptoms. It emphasizes the necessity of considering underlying lymphoma in patients with suspected EGPA who show an atypical or refractory course to conventional therapy. A definitive diagnosis often requires an adequate tissue sample, preferably from a surgical lymph node biopsy, to avoid misdiagnosis and ensure appropriate management. Respiratory physicians should maintain a high index of suspicion for lymphoid malignancies in such complex presentations.
[CASE PRESENTATION] A 55-year-old man presented in 2021 with recurrent wheezing, dyspnea, chronic sinusitis, peripheral eosinophilia (7.35 × 10⁹/L), and skin rash, leading to an initial diagnosis of asthma and later EGPA. Despite treatment with systemic corticosteroids, omalizumab, and mepolizumab, his respiratory symptoms persisted, and lymphadenopathy progressed. A fine-needle lymph node biopsy initially suggested Kimura disease. In 2024, the appearance of a parotid mass prompted further investigation. A subsequent surgical lymph node biopsy in 2025 revealed an effaced nodal architecture with a proliferation of atypical T-cell positive for CD3, CD5, ICOS, and PD-1. T-cell receptor gene rearrangement demonstrated clonality, and Epstein-Barr virus-encoded RNA was detected in situ. These findings confirmed the diagnosis of AITL. Treatment was switched to the CHOP chemotherapy regimen, leading to symptomatic improvement and normalization of eosinophil counts.
[CONCLUSION] This case underscores that AITL can closely mimic EGPA, presenting with severe asthma, hypereosinophilia, sinusitis, and systemic symptoms. It emphasizes the necessity of considering underlying lymphoma in patients with suspected EGPA who show an atypical or refractory course to conventional therapy. A definitive diagnosis often requires an adequate tissue sample, preferably from a surgical lymph node biopsy, to avoid misdiagnosis and ensure appropriate management. Respiratory physicians should maintain a high index of suspicion for lymphoid malignancies in such complex presentations.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Influence of Exercise Management for Frail Elderly Cancer Patients on Chemotherapy Tolerance and Complications: A Systematic Review and Meta-Analysis.
- Comparison of Robotic-Assisted and Uniportal Video-Assisted Thoracoscopic Lobectomy for Early-Stage Non-Small Cell Lung Cancer: A Retrospective Cohort Study.
- Absolute risk of developing a second primary cancer after a first primary melanoma: an Australian population-based cohort study.
- Safety and Efficacy of Unilateral and Bilateral Stenting for Hilar Biliary Obstruction: An Updated Systematic Review and Meta-Analysis.
- Facial Nerve Tractography of Vestibular Schwannomas: A Systematic Review of MR Acquisition and Analysis Pipelines.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Microplastics as environmental modifiers of lung disease.
- Optimizing Liver Transplant Allocation for Hepatocellular Carcinoma: Development and Validation of a Survival Benefit-Based Model.
- Silent invaders: the role of MPs on epithelium inflammation and damage in airway diseases.
- Radon and Non-Cancer Pulmonary Health Effects in Children: A State of The Art Review.
- Radiotherapy in addition to systemic therapy reduces the early mortality of angioimmunoblastic T-cell lymphoma.
- Clinical and Pathophysiological Characteristics of Patients in Whom Asthma Developed during Treatment with Immune Checkpoint Inhibitors: A Retrospective Single-center Study.